Xiaoping Cai
Impact in
-
- Advanced biosensing and bioanalysis techniques
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Circular RNAs in diseases
- Protein Interaction Studies and Fluorescence Analysis
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 4
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
- Retinoids in leukemia and cellular processes 2
- Oncology 7
- Co-authors
- Paul K. Witting (4 shared papers)Zhuo Cao (9 shared papers)Ben Freedman (4 shared papers)Wei Zheng (4 shared papers)Junping Zhang (4 shared papers)Hao Zheng (7 shared papers)Aihua Zhang (2 shared papers)Yuling Li (7 shared papers)
In The Last Decade
Xiaoping Cai
31 papers receiving 298 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 194
- Cancer Research 39
- Molecular Medicine 12
- Complementary and alternative medicine 19
- Nephrology 14
Countries citing papers authored by Xiaoping Cai
This map shows the geographic impact of Xiaoping Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Cai more than expected).
Fields of papers citing papers by Xiaoping Cai
This network shows the impact of papers produced by Xiaoping Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Cai. The network helps show where Xiaoping Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 28 | |
| 2 | 2017 | 28 | |
| 3 | 2015 | 27 | |
| 4 | 2022 | 21 | |
| 5 | 2020 | 20 | |
| 6 | 2021 | 19 | |
| 7 | 1969 | 17 | |
| 8 | 2019 | 17 | |
| 9 | 2016 | 16 | |
| 10 | 2013 | 15 | |
| 11 | 2019 | 15 | |
| 12 | 2021 | 10 | |
| 13 | 2017 | 9 | |
| 14 | 2021 | 9 | |
| 15 | 2024 | 7 | |
| 16 | 2016 | 5 | |
| 17 | [beta-elemene enhances aclarubicin-induced apoptotic effect in HL-60 cells and its mechanism.]. | 2009 | 5 |
| 18 | 2016 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 2024 | 4 |
About Xiaoping Cai
Xiaoping Cai is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 32 papers that have together received 301 indexed citations. Recurring topics across this work include Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers), Electrochemical sensors and biosensors (3 papers), Acute Myeloid Leukemia Research (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Lung Cancer Treatments and Mutations (3 papers), Pancreatitis Pathology and Treatment (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Molecular Biology (194 citations), Cancer Research (39 citations), Molecular Medicine (12 citations), Complementary and alternative medicine (19 citations) and Nephrology (14 citations). Xiaoping Cai has collaborated with scholars based in China and Australia. Frequent co-authors include Paul K. Witting, Zhuo Cao, Ben Freedman, Wei Zheng, Junping Zhang, Hao Zheng, Aihua Zhang, Yuling Li, Xiaosuo Wang and Liangxing Wang. Their work appears in journals such as Discovery Medicine, International Journal of Molecular Sciences, Molecules, Journal of Pharmacy and Pharmacology and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.